Literature DB >> 21618125

Mucin O-glycan branching enzymes: structure, function, and gene regulation.

Pi-Wan Cheng1, Prakash Radhakrishnan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21618125      PMCID: PMC7032653          DOI: 10.1007/978-1-4419-7877-6_25

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  134 in total

Review 1.  The genetic regulation of fucosylated and sialylated antigens on developing myeloid cells.

Authors:  W M Watkins; J L Clarke
Journal:  Adv Exp Med Biol       Date:  2001       Impact factor: 2.622

2.  Molecular cloning and characterization of a novel UDP-GlcNAc:GalNAc-peptide beta1,3-N-acetylglucosaminyltransferase (beta 3Gn-T6), an enzyme synthesizing the core 3 structure of O-glycans.

Authors:  Toshie Iwai; Niro Inaba; Andreas Naundorf; Yan Zhang; Masanori Gotoh; Hiroko Iwasaki; Takashi Kudo; Akira Togayachi; Yasuko Ishizuka; Hiroshi Nakanishi; Hisashi Narimatsu
Journal:  J Biol Chem       Date:  2002-01-30       Impact factor: 5.157

3.  The cytosolic and transmembrane domains of the beta 1,6 N-acetylglucosaminyltransferase (C2GnT) function as a cis to medial/Golgi-targeting determinant.

Authors:  Mourad Zerfaoui; Minoru Fukuda; Claire Langlet; Sylvie Mathieu; Misa Suzuki; Dominique Lombardo; Assou El-Battari
Journal:  Glycobiology       Date:  2002-01       Impact factor: 4.313

4.  Post-translational modifications of recombinant P-selectin glycoprotein ligand-1 required for binding to P- and E-selectin.

Authors:  F Li; P P Wilkins; S Crawley; J Weinstein; R D Cummings; R P McEver
Journal:  J Biol Chem       Date:  1996-02-09       Impact factor: 5.157

5.  Haploinsufficiency of C2GnT-I glycosyltransferase renders T lymphoma cells resistant to cell death.

Authors:  Paula V Cabrera; Maho Amano; Junya Mitoma; Jessica Chan; Jonathan Said; Minoru Fukuda; Linda G Baum
Journal:  Blood       Date:  2006-06-15       Impact factor: 22.113

6.  N-glycans of core2 beta(1,6)-N-acetylglucosaminyltransferase-I (C2GnT-I) but not those of alpha(1,3)-fucosyltransferase-VII (FucT-VII) are required for the synthesis of functional P-selectin glycoprotein ligand-1 (PSGL-1): effects on P-, L- and E-selectin binding.

Authors:  Maëlle Prorok-Hamon; Frédéric Notel; Sylvie Mathieu; Claire Langlet; Minoru Fukuda; Assou El-Battari
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

7.  Regulation of sialyl-Lewis x epitope expression by TNF-alpha and EGF in an airway carcinoma cell line.

Authors:  Yuji Ishibashi; Yoshio Inouye; Teruo Okano; Akiyoshi Taniguchi
Journal:  Glycoconj J       Date:  2005-02       Impact factor: 2.916

8.  Core 2 oligosaccharides mediate eosinophil and neutrophil peritoneal but not lung recruitment.

Authors:  David H Broide; Marina Miller; Diego Castaneda; Jyothi Nayar; Jae Youn Cho; Mark Roman; Lesley G Ellies; P Sriramarao
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-02       Impact factor: 5.464

Review 9.  Cell surface-associated mucins in signal transduction.

Authors:  Pankaj K Singh; Michael A Hollingsworth
Journal:  Trends Cell Biol       Date:  2006-08-09       Impact factor: 20.808

10.  O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1.

Authors:  Hector F Valenzuela; Karen E Pace; Paula V Cabrera; Rachel White; Katja Porvari; Helena Kaija; Pirkko Vihko; Linda G Baum
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

View more
  9 in total

1.  Golgi phosphoprotein 3 determines cell binding properties under dynamic flow by controlling Golgi localization of core 2 N-acetylglucosaminyltransferase 1.

Authors:  Mohamed F Ali; Vishwanath B Chachadi; Armen Petrosyan; Pi-Wan Cheng
Journal:  J Biol Chem       Date:  2012-10-01       Impact factor: 5.157

2.  Non-muscle myosin IIA transports a Golgi glycosyltransferase to the endoplasmic reticulum by binding to its cytoplasmic tail.

Authors:  Armen Petrosyan; Mohamed F Ali; Shailendra Kumar Verma; Helen Cheng; Pi-Wan Cheng
Journal:  Int J Biochem Cell Biol       Date:  2012-04-13       Impact factor: 5.085

3.  TNFα enhances the motility and invasiveness of prostatic cancer cells by stimulating the expression of selective glycosyl- and sulfotransferase genes involved in the synthesis of selectin ligands.

Authors:  Prakash Radhakrishnan; Vishwanath Chachadi; Ming-Fong Lin; Rakesh Singh; Reiji Kannagi; Pi-Wan Cheng
Journal:  Biochem Biophys Res Commun       Date:  2011-05-08       Impact factor: 3.575

4.  Keratin 1 plays a critical role in golgi localization of core 2 N-acetylglucosaminyltransferase M via interaction with its cytoplasmic tail.

Authors:  Armen Petrosyan; Mohamed F Ali; Pi-Wan Cheng
Journal:  J Biol Chem       Date:  2015-01-20       Impact factor: 5.157

5.  A non-enzymatic function of Golgi glycosyltransferases: mediation of Golgi fragmentation by interaction with non-muscle myosin IIA.

Authors:  Armen Petrosyan; Pi-Wan Cheng
Journal:  Glycobiology       Date:  2013-02-07       Impact factor: 4.313

6.  Expression of core 3 synthase in human pancreatic cancer cells suppresses tumor growth and metastasis.

Authors:  Prakash Radhakrishnan; Paul M Grandgenett; Ashley M Mohr; Stephanie K Bunt; Fang Yu; Sanjib Chowdhury; Michael A Hollingsworth
Journal:  Int J Cancer       Date:  2013-08-05       Impact factor: 7.396

Review 7.  CFTR, mucins, and mucus obstruction in cystic fibrosis.

Authors:  Silvia M Kreda; C William Davis; Mary Callaghan Rose
Journal:  Cold Spring Harb Perspect Med       Date:  2012-09-01       Impact factor: 6.915

Review 8.  Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling).

Authors:  Ryan L Hanson; Michael A Hollingsworth
Journal:  Biomolecules       Date:  2016-07-30

9.  The silence of MUC2 mRNA induced by promoter hypermethylation associated with HBV in Hepatocellular Carcinoma.

Authors:  Yang Ling; Jing Zhu; Lu Gao; Yongping Liu; Changtai Zhu; Rong Li; Lixin Wei; Changsong Zhang
Journal:  BMC Med Genet       Date:  2013-01-25       Impact factor: 2.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.